longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

BLSM

BLSM
26.0952.70%( -0.725 )

LongbridgeAI

BlossomHill Therapeutics Reports Second Quarter 2026 Financial Results

Unusual Whales
Sep 18, 2026 at 11:02 AM
Improved financial position through the successful closing of a larger-than-planned $168.3 million initial public offering.

Source: Unusual Whales The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings

  • Sep 18, 2026 at 10:55 AMWarren Buffett exits Berkshire Hathaway as his son Howard becomes chairman
Blossomhill Therapeutics

Blossomhill Therapeutics

BLSM.US

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--